Comparison of VerifyNow-P2Y(12 )test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?

BACKGROUND: Dual anti-platelet therapy with aspirin and a thienopyridine (DAT) is used to prevent stent thrombosis after percutaneous coronary intervention (PCI). Low response to clopidogrel therapy (LR) occurs, but laboratory tests have a controversial role in the identification of this condition....

Descripción completa

Detalles Bibliográficos
Autores principales: Godino, Cosmo, Mendolicchio, Loredana, Figini, Filippo, Latib, Azeem, Sharp, Andrew SP, Cosgrave, John, Calori, Giliola, Cera, Michela, Chieffo, Alaide, Castelli, Alfredo, Maseri, Attilio, Ruggeri, Zaverio M, Colombo, Antonio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683811/
https://www.ncbi.nlm.nih.gov/pubmed/19419580
http://dx.doi.org/10.1186/1477-9560-7-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683811/
https://www.ncbi.nlm.nih.gov/pubmed/19419580
http://dx.doi.org/10.1186/1477-9560-7-4

Ejemplares similares